Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Stu
about
Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Stu
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Effects of atorvastatin on bio ...... AIDS Clinical Trials Group Stu
@ast
Effects of atorvastatin on bio ...... AIDS Clinical Trials Group Stu
@en
type
label
Effects of atorvastatin on bio ...... AIDS Clinical Trials Group Stu
@ast
Effects of atorvastatin on bio ...... AIDS Clinical Trials Group Stu
@en
prefLabel
Effects of atorvastatin on bio ...... AIDS Clinical Trials Group Stu
@ast
Effects of atorvastatin on bio ...... AIDS Clinical Trials Group Stu
@en
P2093
P2860
P921
P1476
Effects of atorvastatin on bio ...... AIDS Clinical Trials Group Stu
@en
P2093
AIDS Clinical Trials Group Study A5275 Team
Daniel E Nixon
Ellen S Chan
Jordan E Lake
Judith A Aberg
Karin L Klingman
Michael M Lederman
Ronald J Bosch
Sally Hodder
P2860
P356
10.1016/J.JACL.2016.09.017
P407
P577
2016-10-05T00:00:00Z